Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant Women.
This study is currently recruiting participants.
Verified April 2013 by INC Research
Sponsor:
INC Research
Collaborators:
Abbott
Apotex Inc.
Aurobindo
Boehringer Ingelheim Pharmaceuticals
Bristol-Myers Squibb
Cipla Ltd.
Gilead Sciences
HEC Pharm
Hetero USA
IPCA Laboratories Ltd.
Janssen R&D Ireland
Merck
Mylan Laboratories
Novartis
Pfizer
Prinston
Ranbaxy Inc.
Roche Pharma AG
Sciegen Pharmaceuticals
Strides Arcolab Ltd.
Teva Pharmaceuticals USA
ViiV Healthcare (represented by GlaxoSmithKline)
Information provided by (Responsible Party):
INC Research
ClinicalTrials.gov Identifier:
NCT00404989
First received: November 27, 2006
Last updated: April 2, 2013
Last verified: April 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | January 2015 |
| Estimated Primary Completion Date: | No date given |